MediWound (MDWD) Competitors

MediWound (NASDAQ:MDWD) and Opthea (NASDAQ:OPT) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, community ranking, risk, institutional ownership, valuation, media sentiment, earnings, analyst recommendations and dividends.

Does the media refer more to MDWD or OPT?

In the previous week, Opthea had 4 more articles in the media than MediWound. MarketBeat recorded 4 mentions for Opthea and 0 mentions for MediWound. Opthea's average media sentiment score of 0.20 beat MediWound's score of 0.00 indicating that Opthea is being referred to more favorably in the news media.

Company	Overall Sentiment
MediWound	Neutral
Opthea	Neutral

Does the MarketBeat Community prefer MDWD or OPT?

MediWound received 377 more outperform votes than Opthea when rated by MarketBeat users. Likewise, 62.20% of users gave MediWound an outperform vote while only 54.55% of users gave Opthea an outperform vote.

Company	Underperform	Outperform
MediWound	Outperform Votes 395 62.20%	Underperform Votes 240 37.80%
Opthea	Outperform Votes 18 54.55%	Underperform Votes 15 45.45%

Do analysts prefer MDWD or OPT?

MediWound currently has a consensus price target of $27.50, suggesting a potential upside of 55.15%. Opthea has a consensus price target of $12.00, suggesting a potential upside of 139.04%. Given Opthea's stronger consensus rating and higher probable upside, analysts clearly believe Opthea is more favorable than MediWound.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MediWound	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
Opthea	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	3.50

Is MDWD or OPT more profitable?

Opthea has a net margin of 0.00% compared to MediWound's net margin of -142.29%. Opthea's return on equity of 0.00% beat MediWound's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
MediWound	-142.29%	-82.17%	-33.67%
Opthea	N/A	N/A	N/A

Which has more volatility & risk, MDWD or OPT?

MediWound has a beta of 0.81, indicating that its share price is 19% less volatile than the S&P 500. Comparatively, Opthea has a beta of 1.08, indicating that its share price is 8% more volatile than the S&P 500.

Which has preferable earnings & valuation, MDWD or OPT?

MediWound has higher revenue and earnings than Opthea.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MediWound	$18.69M	10.23	-$6.72M	-$2.90	-6.11
Opthea	$124.67K	6,197.42	-$220.24M	N/A	N/A

Do institutionals & insiders have more ownership in MDWD or OPT?

46.8% of MediWound shares are owned by institutional investors. Comparatively, 56.0% of Opthea shares are owned by institutional investors. 9.2% of MediWound shares are owned by company insiders. Comparatively, 3.2% of Opthea shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Opthea beats MediWound on 11 of the 17 factors compared between the two stocks.